World Liquid Biopsy Market Report 2022: Assay Has Many Potential Applications in Clinical Oncology – – QNT Press Release

This “World Liquid Biopsy Market 2021” report added to’s supply.

While tissue biopsy and imaging techniques remain the current standard of care for solid tumor diagnosis, they have risks, limitations, and limitations, some of which can be overcome through the use of liquid biopsy in clinical oncology, as an alternative or complementary technique to current care standard.

The report contains the latest information and useful business planning data points:

  • Research and Clinical Liquid Biopsy

  • Liquid Biopsy Market by Region

  • Liquid Biopsy Market by Analyte Type

  • CTC-Based Liquid Biopsy Market

  • ctDNA-based liquid biopsy market

  • EV and exosome-based liquid biopsy market

  • Multi-analyte-based liquid biopsy market

  • Other Liquid Biopsy Markets

  • Liquid Biopsy Market by Cancer Type (Breast, Lung, Colorectal, Ovarian, Prostate, Pan-Cancer, Other Cancers)

  • Selected ctDNA-based liquid biopsy tests in development

  • Selected market-available CTC-based liquid biopsy tests in 2021

  • Selected Liquid Biopsy Tests to Assess Multiple Analytes in 2021

Liquid biopsy testing has many potential applications in clinical oncology, including:

  • Early detection and diagnosis/screening

  • Alternative testing methods when tissue biopsy is difficult/impossible, or when the primary site of metastatic disease is unknown

  • Treatment personalization and monitoring – Through molecular characterization of a patient’s disease, clinicians can choose the best course of treatment and monitor efficacy over time, and respond quickly to adjust…

The full story is available on

Source link

Recommended For You

About the Author: News Center